Alastair Clemow, PhD

Dr. Clemow serves as Chairman of Ensemble Orthopedics, an upper extremity implant company. Prior to this, he managed a number of  early stage technologies including Regentis Biomaterials, Nexgen Spine and Minimally Invasive Surgical Technologies. Previously, Dr. Clemow spent 20 years at Johnson & Johnson in senior executive positions including Worldwide Vice President for Business Development. Dr. Clemow graduated from the University of Surrey (UK) with a BSc and PhD in metallurgy and from Columbia University with an MBA. He is a Past President of the Society for Biomaterials.